Autonomic Modulation in Takotsubo Syndrome

Status Recruiting

Clinical Trial Summary

This is a minimal risk case-controlled single arm intervention study, including 10 patients with a prior history of takotsubo and 10-age and sex matched healthy controls. Subjects will undergo in laboratory testing to measure autonomic function. They will then undergo a 15-week program of device-guided breathing with remote measures of autonomic function obtained at home. Analysis will determine the reproducibility of home autonomic measures and the provide preliminary data to determine the efficacy of device-guided breathing on autonomic measures and quality of life in patients with takotsubo.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03324529
Study type	Interventional
Source	NYU Langone Health
Contact	Harmony Reynolds
Phone	646-501-0302
Email	brokenheartstudy@nyumc.org
Status	Recruiting
Phase	N/A
Start date	October 1, 2021
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03726528` - Optimized Characterization of Takotsubo Syndrome by Obtaining Pressure Volume Loops	N/A
Recruiting	`NCT04634487` - Polish Registry of Takotsubo Syndrome
Completed	`NCT01249599` - Stress-induced Vascular Dysfunction: Evaluation of Endothelial Function in a Cohort of Patients With Takotsubo Syndrome	N/A
Recruiting	`NCT05731830` - Takotsubo Syndrome and Air Pollution
Completed	`NCT03801694` - Predicting the Development of Myocardial Depression in Acute Neurological Patients
Recruiting	`NCT04666454` - BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.	Phase 4
Terminated	`NCT02867878` - Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome	Phase 2
Recruiting	`NCT04361994` - The GErman Italian Spanish Takotsubo (GEIST) Registry